As the election nears, an issue that is top of mind for many healthcare professionals is reproductive health. The topic was the center of discussion during a Monday panel at HLTH 2024 in Las Vegas.
The past couple of years have been rocky for companies looking to disrupt the traditional primary care model — with top retailers Walmart and Walgreens announcing that they’re winding down ...
Despite today’s technological advancements, a large amount of prior authorization requests are submitted via fax machine. A new partnership between Blue Shield of California and Salesforce will ...
Investors pour billions of dollars into cancer research and treatment innovation each year. However, pennies on the dollar are directed toward rare cancers and cancers such as cervical cancer that ...
When Kaiser Permanente CEO Greg Adams thinks about the tall task of advancing value-based care throughout the country, he harkens back to an idea often mentioned by his organization’s founder ...
Electrophysiology procedures take place in hospitals. That’s been the widely held assumption — until now. There’s plenty of reasons that people think EP procedures belong in hospitals.
The 2022 Dobbs v. Jackson decision tore away the constitutional right to abortion, allowing states to restrict and outright ban the procedure. Today, abortion is prohibited in 13 states, and it ...
Women in these areas face increased travel distances, higher costs, and logistical challenges, disproportionately affecting low-income women and women of color, exacerbating existing health ...
HLTH 2024 at the Venetian Expo Center in Las Vegas on October 20 to 23 will spotlight a variety of startups that want to improve care coordination for providers, detect diseases earlier, improve ...
A new study published in the New England Journal of Medicine Catalyst showed that Waymark’s community-based interventions lowered hospital and emergency department visits and improved care quality.
What a difference a few years make. Previously, digital strategy in the biopharma industry consisted of a series of isolated projects and fragmented channels, websites, and portals. Today ...
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial carcinoma, a move that comes nearly five months after the ...